By Sriparna Roy March 18 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson's oral pill for ...

The clearance is the first for an oral peptide that blocks IL-23, the target of popular medicines like Skyrizi and Tremfya. J ...

Johnson & Johnson won U.S. approval for a daily psoriasis pill that rivals the benefits of injectable medicines and could ...

Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to ...

The FDA clears 1st oral pill for plaque psoriasis, approving Johnson & Johnson’s Icotyde for adults and pediatric patients age 12 and older.

The first-of-its-kind oral pill could replace injectable medications for some patients with psoriasis, dermatologists say.

One pill for obesity is already on the market, and more are on the way. But the injected drugs have key advantages.

J&J’s Icotyde will take on AbbVie’s blockbuster injectable Skyrizi as analysts forecast a blockbuster future for the pill.

Structure Therapeutics Inc.’s shares rose after more data on the company’s experimental weight-loss pill showed it’s shaping ...

Fake news can be tricky to spot, but spotting fake drugs just got a little easier. Researchers have devised a low-cost way to ...